Supernus Pharmaceuticals, Inc. (SUPN)
49.08
+0.68
(+1.40%)
USD |
NASDAQ |
Feb 04, 16:00
49.11
+0.03
(+0.06%)
After-Hours: 20:00
Supernus Pharmaceuticals Total Assets (Quarterly) : 1.420B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 1.052B |
| Vertex Pharmaceuticals, Inc. | 24.86B |
| Assembly Biosciences, Inc. | 240.00M |
| Amphastar Pharmaceuticals, Inc. | 1.666B |
| Krystal Biotech, Inc. | 1.240B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 370.09M |
| Shareholders Equity (Quarterly) | 1.050B |
| Debt to Equity Ratio | 0.0402 |
| Current Ratio | 1.796 |
| Net Debt Paydown Yield | -0.02% |